Cargando…
Dipeptidylpeptidase 4 promotes survival and stemness of acute myeloid leukemia stem cells
Leukemic-stem-cell-specific targeting may improve the survival of patients with acute myeloid leukemia (AML) by avoiding the ablative effects of standard regimens on normal hematopoiesis. Herein, we perform an unbiased screening of compounds targeting cell surface proteins and identify clinically us...
Autores principales: | Wang, Chen, Nistala, Ravi, Cao, Min, Pan, Yi, Behrens, Madelaine, Doll, Donald, Hammer, Richard D., Nistala, Puja, Chang, Hui-Ming, Yeh, Edward T.H., Kang, XunLei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432577/ https://www.ncbi.nlm.nih.gov/pubmed/36807138 http://dx.doi.org/10.1016/j.celrep.2023.112105 |
Ejemplares similares
-
The Role of T Cell Immunotherapy in Acute Myeloid Leukemia
por: Hao, Fang, et al.
Publicado: (2021) -
CXCR2 inhibition overcomes ponatinib intolerance by eradicating chronic myeloid leukemic stem cells through PI3K/Akt/mTOR and dipeptidylpeptidase Ⅳ (CD26)
por: Kim, Ji-Hea, et al.
Publicado: (2023) -
The quest for personalized B-cell depletion therapy in rheumatic disease
por: Nistala, Kiran, et al.
Publicado: (2014) -
Chronic myeloid leukemia stem cells
por: Houshmand, Mohammad, et al.
Publicado: (2019) -
Leukemia stem cells: the root of chronic myeloid leukemia
por: Zhou, Hong, et al.
Publicado: (2015)